投資評等
最後更新日期：2024/5/19
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2015/12/18 | Sterne Agee CRT | Neutral >> Buy | |
| 2014/10/10 | UBS | Sell >> Neutral | $12.50 >> $11 |
| 2013/10/31 | Standpoint Research | Hold >> Buy | 22 |
| 2013/3/14 | Stifel | Hold >> Buy | 26 |
| 2012/5/1 | Standpoint Research | Hold >> Buy | 24 |
| 2011/12/14 | Caris & Company | Average >> Above Average | $21 >> $19 |
| 2011/7/7 | UBS | Neutral >> Buy | $29 >> $33 |
| 2011/5/4 | Caris & Company | Below Average >> Average | 32 |
| 2010/1/8 | Caris & Company | Above Average >> Buy | 45 |
| 2009/7/21 | BMO Capital Markets | Market Perform >> Outperform | |
| 2006/5/19 | HSBC Securities | Underweight Neutral | |
| 2005/2/2 | Smith Barney Citigroup | Sell->Hold | |
| 2004/2/4 | UBS | Neutral->Buy | |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2012/5/21 | UBS | Neutral >> Sell | $23 >> $13 |
| 2011/2/9 | Caris & Company | Average >> Below Average | $32 >> $25 |
| 2011/1/5 | UBS | Buy >> Neutral | $40 >> $32 |
| 2010/11/8 | Barclays Capital | Overweight >> Equal Weight | $35 >> $31 |
| 2010/10/29 | Caris & Company | Buy >> Average | $45 >> $32 |
| 2009/12/7 | BMO Capital Markets | Outperform >> Market Perform | |
| 2009/6/1 | Caris & Company | Buy >> Above Average | |
| 2009/3/9 | BMO Capital Markets | Market Perform Underperform | |
| 2009/1/16 | BMO Capital Markets | Outperform Market Perform | |
| 2006/2/3 | HSBC Securities | Neutral Underweight | |
| 2005/9/21 | Morgan Stanley | Overweight->Equal-weight | |
| 2004/12/9 | Oppenheimer | Buy->Neutral | |
| 2004/11/1 | Deutsche Securities | Buy->Hold | |
| 2002/8/16 | Bernstein | Outperform -> Mkt Perform | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2011/11/3 | Standpoint Research | Buy | 25 |
| 2009/12/4 | Wedbush Morgan | Outperform | 45 |
| 2009/4/22 | RBC Capital Mkts | Sector Perform | 22 |
| 2005/8/5 | CSFB | Underperform | 33 |
| 2005/4/5 | Bear Stearns | Peer Perform | |
| 2004/12/15 | Fulcrum | Neutral | 44 |
| 2004/7/7 | Morgan Stanley | Overweight | 54 |
| 2003/10/7 | CSFB | Neutral | 70 |
| 2003/5/13 | Deutsche Securities | Buy | |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 查無資料 | | | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2015/12/4 | Citigroup | Buy | $5 >> $6 |
| 2015/7/31 | UBS | Neutral | $8 >> $5.50 |
| 2011/9/2 | Barclays Capital | Equal Weight | $28 >> $26 |
| 2011/7/29 | Caris & Company | Average | $32 >> $27 |
| 2011/2/9 | Deutsche Bank | Buy | $36 >> $34 |
| 2011/2/9 | UBS | Neutral | $32 >> $29 |
| 2011/2/8 | Wedbush | Outperform | $40 >> $35 |
| 2010/6/17 | Caris & Company | Buy | $45 >> $44 |
| 2010/4/7 | Stifel Nicolaus | Buy | $36 >> $39 |
| 2009/11/23 | Barclays Capital | Overweight | $38 >> $40 |